Рак молочной железы

AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain - UCLA Health

AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain UCLA Health

More Than a Pink Ribbon: What Breast Cancer Awareness Month Really Means for Black Women - Black Health Matters

More Than a Pink Ribbon: What Breast Cancer Awareness Month Really Means for Black Women Black Health Matters

When Bone-Only HR+/HER2− Breast Cancer Turns Visceral: What PR Expression May Tell Us in the CDK4/6 Era - Oncodaily

When Bone-Only HR+/HER2− Breast Cancer Turns Visceral: What PR Expression May Tell Us in the CDK4/6 Era Oncodaily

Debating Camizestrant, ctDNA Monitoring, and SERENA-6 in HR+ Breast Cancer

EU Approves T-DXd/Pertuzumab for Frontline HER2+ Metastatic Breast Cancer

2026 Life After Breast Cancer conference features HHS experts - Hamilton Health Sciences

2026 Life After Breast Cancer conference features HHS experts Hamilton Health Sciences

eBook: PET imaging for early treatment response prediction in breast cancer - Oncology Central

eBook: PET imaging for early treatment response prediction in breast cancer Oncology Central

Heart trial after breast cancer has 'improved my life' - AOL.com

Heart trial after breast cancer has 'improved my life' AOL.com

BCRF Award Supports AI Platform to Improve Breast Cancer Survivorship Care - University of Miami

BCRF Award Supports AI Platform to Improve Breast Cancer Survivorship Care University of Miami

Low-dose THC keeps breast cancer cells in tumor models from reverting to an aggressive state

Recent discoveries have revealed that breast cancer cells are more flexible than previously thought. Some can change from a differentiated state, when a mature cell has taken on a specific function, back to a more stem-like state. From there, they can become more invasive and resistant to treatment.

Stress and depression, not heart damage, may drive long-term breast cancer fatigue

For breast cancer survivors, new research shows that feelings of depression and perceptions of psychological stress make the biggest difference in whether they experience fatigue up to two years after chemotherapy started.

Top 9 Takeaways From ASCO’s 2026 Breast Cancer Surveillance Update

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer - Yahoo Finance

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer Yahoo Finance

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer - PR Newswire

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer PR Newswire

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer - Yahoo Finance

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer Yahoo Finance